Pernille Tine Jensen

Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer : AGO DESKTOP III/ENGOT ov20. / Du Bois, Andreas; Vergote, Ignace; Ferron, Gwenael; Reuss, Alexander; Meier, Werner; Greggi, Stefano; Jensen, Pernille Tina; Selle, Frededric; Guyon, Frederic; Pomel, Christophe; Lecuru, Fabrice; Zang, Rongyu; Avall-Lundqvist, Elisabeth; Kim, Jae Weon; Ponce, Jordi; Raspagliesi, Francesco; Ghaem-Maghami, Sadaf; Reinthaller, Alexander; Harter, Philipp; Sehouli, Jalid.

I: Journal of Clinical Oncology, Bind 35, 20.05.2017.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Du Bois, A, Vergote, I, Ferron, G, Reuss, A, Meier, W, Greggi, S, Jensen, PT, Selle, F, Guyon, F, Pomel, C, Lecuru, F, Zang, R, Avall-Lundqvist, E, Kim, JW, Ponce, J, Raspagliesi, F, Ghaem-Maghami, S, Reinthaller, A, Harter, P & Sehouli, J 2017, 'Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20', Journal of Clinical Oncology, bind 35. https://doi.org/10.1200/JCO.2017.35.15_suppl.5501

APA

Du Bois, A., Vergote, I., Ferron, G., Reuss, A., Meier, W., Greggi, S., Jensen, P. T., Selle, F., Guyon, F., Pomel, C., Lecuru, F., Zang, R., Avall-Lundqvist, E., Kim, J. W., Ponce, J., Raspagliesi, F., Ghaem-Maghami, S., Reinthaller, A., Harter, P., & Sehouli, J. (2017). Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20. Journal of Clinical Oncology, 35. https://doi.org/10.1200/JCO.2017.35.15_suppl.5501

CBE

Du Bois A, Vergote I, Ferron G, Reuss A, Meier W, Greggi S, Jensen PT, Selle F, Guyon F, Pomel C, Lecuru F, Zang R, Avall-Lundqvist E, Kim JW, Ponce J, Raspagliesi F, Ghaem-Maghami S, Reinthaller A, Harter P, Sehouli J. 2017. Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20. Journal of Clinical Oncology. 35. https://doi.org/10.1200/JCO.2017.35.15_suppl.5501

MLA

Vancouver

Author

Du Bois, Andreas ; Vergote, Ignace ; Ferron, Gwenael ; Reuss, Alexander ; Meier, Werner ; Greggi, Stefano ; Jensen, Pernille Tina ; Selle, Frededric ; Guyon, Frederic ; Pomel, Christophe ; Lecuru, Fabrice ; Zang, Rongyu ; Avall-Lundqvist, Elisabeth ; Kim, Jae Weon ; Ponce, Jordi ; Raspagliesi, Francesco ; Ghaem-Maghami, Sadaf ; Reinthaller, Alexander ; Harter, Philipp ; Sehouli, Jalid. / Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer : AGO DESKTOP III/ENGOT ov20. I: Journal of Clinical Oncology. 2017 ; Bind 35.

Bibtex

@article{79f7cfdc70c648a293b5714d8f7cab21,
title = "Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20",
author = "{Du Bois}, Andreas and Ignace Vergote and Gwenael Ferron and Alexander Reuss and Werner Meier and Stefano Greggi and Jensen, {Pernille Tina} and Frededric Selle and Frederic Guyon and Christophe Pomel and Fabrice Lecuru and Rongyu Zang and Elisabeth Avall-Lundqvist and Kim, {Jae Weon} and Jordi Ponce and Francesco Raspagliesi and Sadaf Ghaem-Maghami and Alexander Reinthaller and Philipp Harter and Jalid Sehouli",
year = "2017",
month = may,
day = "20",
doi = "10.1200/JCO.2017.35.15_suppl.5501",
language = "English",
volume = "35",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
note = "53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET ; Conference date: 02-06-2017 Through 07-06-2017",

}

RIS

TY - JOUR

T1 - Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer

T2 - 53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET

AU - Du Bois, Andreas

AU - Vergote, Ignace

AU - Ferron, Gwenael

AU - Reuss, Alexander

AU - Meier, Werner

AU - Greggi, Stefano

AU - Jensen, Pernille Tina

AU - Selle, Frededric

AU - Guyon, Frederic

AU - Pomel, Christophe

AU - Lecuru, Fabrice

AU - Zang, Rongyu

AU - Avall-Lundqvist, Elisabeth

AU - Kim, Jae Weon

AU - Ponce, Jordi

AU - Raspagliesi, Francesco

AU - Ghaem-Maghami, Sadaf

AU - Reinthaller, Alexander

AU - Harter, Philipp

AU - Sehouli, Jalid

PY - 2017/5/20

Y1 - 2017/5/20

U2 - 10.1200/JCO.2017.35.15_suppl.5501

DO - 10.1200/JCO.2017.35.15_suppl.5501

M3 - Journal article

VL - 35

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

Y2 - 2 June 2017 through 7 June 2017

ER -